A new study has found that consuming sugary foods and drinks like smoothies can increase the gastrointestinal side effects ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Myth #2: Older men are at highest risk for testicular cancer. Most cancers often affect older people, but testicular cancer does not. People in their teens, 20s, and 30s are more likely to get ...

If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...

How long you have your drain depends on your surgery and how much fluid is draining from your incision. As your incision heals, you’ll have less fluid. When no fluid drains from your Penrose drain for ...

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

Research at MSK Our research impact Research topics Core facilities & resources ...

DNA replication, repair, and damage response, collectively called the 3Rs, support genome stability and faithful genetic inheritance. Proteins involved in the 3Rs are genome guardians that prevent a ...

Acoustic neuroma — also called vestibular schwannoma — is a type of noncancerous tumor within the skull. It can cause problems with movement, balance, and hearing. Memorial Sloan Kettering experts can ...

For people living with advanced triple-negative breast cancer (TNBC), a newly approved treatment may offer more time and a better quality of life. TNBC makes up about 10% to 20% of all breast cancers, ...

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.

Thoracic oncologist Kathryn Arbour, MD, led the Phase 1/2 clinical trial of daraxonrasib at MSK for metastatic lung cancer. The drug was approved by the FDA for pancreatic cancer in August 2026 and Dr ...